Azoramide protects iPSC-derived dopaminergic neurons with PLA2G6 D331Y mutation through restoring ER function and CREB signaling
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The endoplasmic reticulum (ER)-stress-induced cascade events are implicated in Parkinson’s disease (PD). The discovery of drug candidates to protect dopaminergic (DA) neurons from ER-stress-induced oxidative damage is important to resolve the pathological aspects of PD and modify its progress. In this study, we found that a recently identified unfolded protein response (UPR) modulator, azoramide, showed protective effects on patient induced pluripotent stem cells-derived midbrain DA neurons with the homozygous phospholipase A2 group 6 (PLA2G6) D331Y mutant. A series of PD-related cascade events such as ER stress, abnormal calcium homeostasis, mitochondrial dysfunction, increase of reactive oxygen species, and apoptosis were observed in PLA2G6 D331Y mutant DA neurons, whereas azoramide significantly protected PLA2G6 D331Y mutant DA neurons against these events. The beneficial effects of azoramide were abolished by treatment with a cAMP-response element binding protein (CREB) inhibitor. Our results suggest that azoramide is a potential neuroprotectant against DA neuron damage via restoring ER function and the CREB signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in PLA2G6 lead to the accumulation of abnormal phospholipids, disrupting mitochondrial structure and function. This results in impaired mitochondrial dynamics, defective oxidative phosphorylation, increased reactive oxygen species (ROS) production, reduced ATP levels and activation of apoptosis (Beck et al., 2011; Paradies et al., 2019; Ke et al., 2020).”
From Decanoic acid extends lifespan and modulates metabolism in models of PLA2G6 -associated neurodegeneration (2025) · cites this paper as Ke et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chong, C.-M., Ke, M., Tan, Y., Huang, Z., Zhang, K., Ai, N., Ge, W., Qin, D., Lu, J.-H., & Su, H. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0945-7 · Cited by 66
Self-citation
Research works printed but not linked: 46
- Dodson, P. D. et al. Representation of spontaneous movement by dopaminergic neurons is cell-type selective and disrupted in parkinsonism. Proc. Natl. Acad. Sci. USA 113, E2180–E2188 (2016). · DOI · Paper page
- Luo, S. X. & Huang, E. J. Dopaminergic neurons and brain reward pathways: from neurogenesis to circuit assembly. Am. J. Pathol. 186, 478–488 (2016). · DOI · Paper page
- Bissonette, G. B. & Roesch, M. R. Development and function of the midbrain dopamine system: what we know and what we need to. Genes Brain Behav. 15, 62–73 (2016). · DOI · Paper page
- Zhou, C., Huang, Y. & Przedborski, S. Oxidative stress in Parkinson’s disease: a mechanism of pathogenic and therapeutic significance. Ann. N. Y. Acad. Sci. 1147, 93–104 (2008). · DOI · Paper page
- Mercado, G., Valdes, P. & Hetz, C. An ERcentric view of Parkinson’s disease. Trends Mol. Med 19, 165–175 (2013). · DOI · Paper page
- Acosta-Alvear, D. et al. The unfolded protein response and endoplasmic reticulum protein targeting machineries converge on the stress sensor IRE1. Elife 7, pii: e43036 (2018). · DOI · Paper page
- Hetz, C. & Saxena, S. ER stress and the unfolded protein response in neurodegeneration. Nat. Rev. Neurol. 13, 477–491 (2017). · DOI · Paper page
- Martinez, A., Lopez, N., Gonzalez, C. & Hetz, C. Targeting of the unfolded protein response (UPR) as therapy for Parkinson’s disease. Biol. Cell 111, 161–168 (2019). · DOI
- Smaili, S. S. et al. Mitochondria, calcium and pro-apoptotic proteins as mediators in cell death signaling. Braz. J. Med Biol. Res. 36, 183–190 (2003). · DOI
- Pinton, P., Giorgi, C., Siviero, R., Zecchini, E. & Rizzuto, R. Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis. Oncogene 27, 6407–6418 (2008). · DOI · Paper page
- Kim, K. Y. et al. Interplay of reactive oxygen species, intracellular Ca2+ and mitochondrial homeostasis in the apoptosis of prostate cancer cells by deoxypodophyllotoxin. J. Cell Biochem. 114, 1124–1134 (2013). · DOI
- Klein, C. & Westenberger, A. Genetics of Parkinson’s disease. Cold Spring Harb. Perspect. Med. 2, a008888 (2012). · DOI · Paper page
- Chung, C. Y. et al. Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons. Science 342, 983–987 (2013). · DOI · Paper page
- Lu, C. S. et al. PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson’s disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B, 183–191 (2012). · doi:10.1002/ajmg.b.32012
- Shi, C. H. et al. PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort. Neurology 77, 75–81 (2011). · DOI
- Cheng, Y. C. et al. Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson’s disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene. Stem Cell Res. 37, 101432 (2019). · doi:10.1016/j.scr.2019.101432
- Chiu, C. C. et al. PARK14 (D331Y) PLA2G6 causes early-onset degeneration of substantia nigra dopaminergic neurons by inducing mitochondrial dysfunction, ER stress, mitophagy impairment and transcriptional dysregulation in a knockin mouse model. Mol. Neurobiol. 56, 3835–3853 (2019). · DOI
- Wang, L. et al. Generation of integration-free neural progenitor cells from cells in human urine. Nat. Methods 10, 84–89 (2013). · DOI · Paper page
- Tan, Y. et al. Hydroxyurea facilitates manifestation of disease relevant phenotypes in patients-derived iPSCs-based modeling of late-onset Parkinson’s disease disease. Aging Dis. 10, 1037–1048 (2019). · DOI
- Kinghorn, K. J. et al. Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction. Brain 138, 1801–1816 (2015). · DOI · Paper page
- Ekim Kocabey, A., Kost, L., Gehlhar, M., Rodel, G. & Gey, U. Mitochondrial Sco proteins are involved in oxidative stress defense. Redox Biol. 21, 101079 (2019). · DOI
- Han, S. J., Choi, H. S., Kim, J. I., Park, J. W. & Park, K. M. IDH2 deficiency increases the liver susceptibility to ischemia-reperfusion injury via increased mitochondrial oxidative injury. Redox Biol. 14, 142–153 (2018). · DOI
- Chiu, C. C. et al. PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway. Oncotarget 8, 79046–79060 (2017). · DOI
- Carri, M. T., Valle, C., Bozzo, F. & Cozzolino, M. Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS. Front. Cell Neurosci. 9, 41 (2015).
- Knott, A. B., Perkins, G., Schwarzenbacher, R. & Bossy-Wetzel, E. Mitochondrial fragmentation in neurodegeneration. Nat. Rev. Neurosci. 9, 505–518 (2008). · DOI · Paper page
- Zhou, Q. et al. Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson’s disease. Nat. Commun. 7, 10332 (2016). · DOI · Paper page
- Schafer, C., Rymarczyk, G., Ding, L., Kirber, M. T. & Bolotina, V. M. Role of molecular determinants of store-operated Ca(2+) entry (Orai1, phospholipase A2 group 6, and STIM1) in focal adhesion formation and cell migration. J. Biol. Chem. 287, 40745–40757 (2012). · DOI
- Secondo, A., Bagetta, G. & Amantea, D. On the role of store-operated calcium entry in acute and chronic neurodegenerative diseases. Front. Mol. Neurosci. 11, 87 (2018). · DOI
- Zaichick, S. V., McGrath, K. M. & Caraveo, G. The role of Ca(2+) signaling in Parkinson’s disease. Dis. Model Mech. 10, 519–535 (2017). · DOI · Paper page
- Sehgal, P. et al. Inhibition of the sarco/endoplasmic reticulum (ER) Ca(2+)-ATPase by thapsigargin analogs induces cell death via ER Ca(2+) depletion and the unfolded protein response. J. Biol. Chem. 292, 19656–19673 (2017). · DOI · Paper page
- Wilson, B. E., Mochon, E. & Boxer, L. M. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol. Cell Biol. 16, 5546–5556 (1996). · DOI · Paper page
- Cao, S. S. & Kaufman, R. J. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid. Redox Signal 21, 396–413 (2014). · DOI · Paper page
- Smani, T. et al. A novel mechanism for the store-operated calcium influx pathway. Nat. Cell Biol. 6, 113–120 (2004). · DOI · Paper page
- Bolotina, V. M. Orai, STIM1 and iPLA2beta: a view from a different perspective. J. Physiol. 586, 3035–3042 (2008). · DOI · Paper page
- Gwozdz, T., Dutko-Gwozdz, J., Schafer, C. & Bolotina, V. M. Overexpression of Orai1 and STIM1 proteins alters regulation of store-operated Ca2+ entry by endogenous mediators. J. Biol. Chem. 287, 22865–22872 (2012). · DOI
- Gwozdz, T., Dutko-Gwozdz, J., Zarayskiy, V., Peter, K. & Bolotina, V. M. How strict is the correlation between STIM1 and Orai1 expression, puncta formation, and ICRAC activation? Am. J. Physiol. Cell Physiol. 295, C1133–C1140 (2008). · DOI
- Boittin, F. X., Gribi, F., Serir, K. & Beny, J. L. Ca2+-independent PLA2 controls endothelial store-operated Ca2+ entry and vascular tone in intact aorta. Am. J. Physiol. Heart Circ. Physiol. 295, H2466–H2474 (2008). · DOI
- Fu, S. et al. Phenotypic assays identify azoramide as a small-molecule modulator of the unfolded protein response with antidiabetic activity. Sci. Transl. Med. 7, 292ra298 (2015).
- Jenner, P., Schapira, A. H. & Marsden, C. D. New insights into the cause of Parkinson’s disease. Neurology 42, 2241–2250 (1992). · DOI · Paper page
- Angelova, P. R. et al. Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation. Redox Biol. 14, 474–484 (2018). · DOI · Paper page
- van der Bliek, A. M., Shen, Q. & Kawajiri, S. Mechanisms of mitochondrial fission and fusion. Cold Spring Harb. Perspect. Biol. 5 (2013). · DOI · Paper page
- Shanmughapriya, S. et al. Ca2+ signals regulate mitochondrial metabolism by stimulating CREB-mediated expression of the mitochondrial Ca2+ uniporter gene MCU. Sci. Signal 8, ra23 (2015). · DOI · Paper page
- Sheng, M., Thompson, M. A. & Greenberg, M. E. CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 252, 1427–1430 (1991). · DOI · Paper page
- Wheeler, D. G. et al. Ca(V)1 and Ca(V)2 channels engage distinct modes of Ca(2+) signaling to control CREB-dependent gene expression. Cell 149, 1112–1124 (2012). · DOI · Paper page
- Fasano, C. A., Chambers, S. M., Lee, G., Tomishima, M. J. & Studer, L. Efficient derivation of functional floor plate tissue from human embryonic stem cells. Cell Stem Cell 6, 336–347 (2010). · DOI · Paper page
- Fedele, S. et al. Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential. Sci. Rep. 7, 6036 (2017). · DOI
Cited by
Zhang, B., Dunn, E., Williams, R. S. B., Snowden, S., & Augustin, H. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052184
Metadata
- Authors
- Ke, M., Chong, C.-M., Zeng, H., Huang, M., Huang, Z., Zhang, K., Cen, X., Lu, J.-H., Yao, X., Qin, D., & Su, H.
- Venue
- Cell Death & Disease
- Published
- 2020-02-18
- Volume
- 11
- Issue
- 2
- ISSN
- 2041-4889
- Cited by
- 39
- References
- 1
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Azoramide protects iPSC-derived dopaminergic neurons with PLA2G6 D331Y mutation through restoring ER function and CREB signaling. https://app.cochat.ai/papers/10.1038/s41419-020-2312-8
- The paper
- Ke, M., Chong, C.-M., Zeng, H., Huang, M., Huang, Z., Zhang, K., Cen, X., Lu, J.-H., Yao, X., Qin, D., & Su, H. (2020). Azoramide protects iPSC-derived dopaminergic neurons with PLA2G6 D331Y mutation through restoring ER function and CREB signaling. Cell Death & Disease. https://doi.org/10.1038/s41419-020-2312-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.